ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Biocon receives EIR from US FDA
November 22, 2017Biotechnology firm Biocon has received the Establishment Inspection Report (EIR) with ’voluntary action indicated’ status from the US FDA on closure of inspection of its aseptic drug product facility. -
Granules India gets EIR from USFDA for OmniChem facility
October 09, 2017Granules India has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility at Visakhapatnam, Andhra Pradesh. -
Orchid Pharma gets EIR from US FDA for its Alathur facility
September 25, 2017Orchid Pharma has received establishment inspection report (EIR) from the US health regulator for its Alathur facility in Tamil Nadu.
Pharma Sources Insight January 2025
